Podcast

Pharmacy Focus: Psychedelic Pharmacy - Psilocybin-Assisted Therapy for Binge Eating Disorder

Jim Gilligan, PhD, discusses a phase 2 study investigating psilocybin-assisted therapy for binge eating disorder.

This month, we spoke with Jim Gilligan, PhD, to learn about a phase 2 study investigating the use of psilocybin-assisted therapy for the treatment of binge eating disorder.

Related Videos
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Caregiver holding elderly man's hand -- Image credit: Chinnapong | stock.adobe.com
Ashley Pugh, PharmD, and Lauren Angelo, PharmD, MBA
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Pharmacy Times Public Health Matters Podcast (logo)
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Therapy session -- Image credit: pressmaster | stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
Related Content
Postpartum depression -- Image credit: grooveriderz | stock.adobe.com
December 20th 2024

Study: Predictive Screening Models Less Likely to Widen Existing Health Disparities in PMAD Diagnosis

Gillian McGovern, Assistant Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Breaking Down Barriers to Care and Transforming Pharmacy Professionals’ Mental Health
December 19th 2024

Breaking Down Barriers to Care and Transforming Pharmacy Professionals’ Mental Health

J. Corey Feist, JD, MBA
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
Long-Term Data On Olanzapine and Samidorphan Highlight Maintained Schizophrenia Symptom Control
December 6th 2024

Long-Term Data On Olanzapine and Samidorphan Highlight Maintained Schizophrenia Symptom Control

Aislinn Antrim, Assistant Managing Editor
Teacher and students having class outdoors -- Image credit: pressmaster | stock.adobe.com
December 3rd 2024

Study Finds Nature-Based Interventions at School Does Not Reduce Children’s Poor Mental Health Symptoms

Gillian McGovern, Assistant Editor